List of insiders holdings for CytoMed Therapeutics Ltd:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| 1 | Glorious Finance Ltd 10% Owner | 2023-04-14 16:49:15 | 4,653,604 0 | 4,653,604 | Form 3 |
| 2 | Choo Chee Kong Director 10% Owner | 2026-10-16 06:05:31 | 3,773,291 0 | 3,773,291 | Form 13D |
| 3 | Wang Shu 10% Owner | 2024-02-14 16:00:32 | 883,858 0 | 883,858 | Form 13G |
| 4 | Zeng Jieming CSO and CMO Director | 2024-02-14 16:00:32 | 589,239 0 | 589,239 | Form 13G |
| 5 | Luk Lucas Tien Wee Chief Clinical Officer | 2023-04-14 16:58:12 | 92,563 0 | 92,563 | Form 3 |
| 6 | Goh Yvonne Chief Financial Officer | 2026-05-15 09:00:29 | 25,781 0 | 25,781 | Form 3 |
| 7 | TAN YOONG YING Chief Corporate Officer | 2026-05-15 09:00:31 | 25,781 0 | 25,781 | Form 3 |
| 8 | Toh Keng Kiat Director | 2026-05-26 09:00:15 | 4,000 0 | 4,000 | Form 3 |
| 9 | Yew Chak Hua Director | 2026-05-15 09:00:36 | 2,469 0 | 2,469 | Form 3 |
| 10 | Tan Wee Kiat Chief Operating Officer | 2023-04-14 16:53:43 | 0 0 | 0 | Form 3 |
| 11 | Loh Yuin Han Director | 2023-04-17 06:18:16 | 0 0 | 0 | Form 3 |
| 12 | Leong Mark Kei Wei Director | 2026-05-15 09:00:35 | 0 0 | 0 | Form 3 |